Clinical Trial: An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function

U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962774) titled 'An Investigational Study of ESK-001 in Participants With Normal Renal Function and Participants With Mild, Moderate, and Severe Impaired Renal Function' on April 30.

Brief Summary: This a phase 1, open label, single dose, parallel cohort study to determine the pharmacokinetics (PK) of study drug (ESK-001) in healthy volunteer participants, and participants with mild, moderate, and severe renal impairment.

Study Start Date: May 09

Study Type: INTERVENTIONAL

Condition: Renal Impairment

Intervention: DRUG: ESK-001

Single oral dose of ESK-001 in participants from all cohorts

Recruitment Status: RECRUITING

Sponsor: Alumis Inc

Dis...